NCT06097091 Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
| NCT ID | NCT06097091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Medical University |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 98 participants |
| Start Date | 2023-09-06 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 98 participants in total. It began in 2023-09-06 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trials study aims, first, to determine the effectiveness of a nurse-led PNE program designed by a multidisciplinary team, compared with an active control group on pain intensity, fibromyalgia (FM) severity, pain catastrophizing, and cognitive performance in patients with FM. Second, to determine the mediator role of pain catastrophizing in the effects of PNE on outcomes of interest. Third, to explore PNE-induced changes to the brain circuitry using QEEG in patients with FM.
Eligibility Criteria
Inclusion Criteria: * Participants must read and understand Chinese language. * According to the 2016 ACR diagnostic criteria, participants' PDS scores more than or equal to 13 points Exclusion Criteria: * Subjects who have medical history of traumatic brain injury or neurological disorder. * Subjects who have present psychopathologic disorder. * Subjects who are cancer. * Subjects who are pregnancy.
Contact & Investigator
Pei-Shan Tsai, PhD
STUDY CHAIR
Taipei Medical University
Frequently Asked Questions
Who can join the NCT06097091 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06097091 currently recruiting?
Yes, NCT06097091 is actively recruiting participants. Contact the research team at ptsai@tmu.edu.tw for enrollment information.
Where is the NCT06097091 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06097091 clinical trial?
NCT06097091 is sponsored by Taipei Medical University. The principal investigator is Pei-Shan Tsai, PhD at Taipei Medical University. The trial plans to enroll 98 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.